Peter Llewellyn-Davies, CEO & CFO will be presenting APEIRON Biologics AG at the upcoming European HealthTech CEO Forum.
— Sachs Associates (@SachsAssociates) February 18, 2021
e-Meet APEIRON Biologics AG at #Sachs_EHTF
More info @ https://t.co/HI7OAD4QYO pic.twitter.com/a7K7EFXYZE